Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 16, 2021

SELL
$11.45 - $13.96 $2.91 Million - $3.55 Million
-254,093 Closed
0 $0
Q1 2021

May 17, 2021

SELL
$11.06 - $12.87 $452,431 - $526,473
-40,907 Reduced 13.87%
254,093 $3.04 Million
Q4 2020

Feb 16, 2021

SELL
$9.33 - $12.48 $1.98 Million - $2.64 Million
-211,888 Reduced 41.8%
295,000 $3.66 Million
Q3 2020

Nov 16, 2020

BUY
$10.33 - $14.49 $5.24 Million - $7.34 Million
506,888 New
506,888 $5.3 Million
Q4 2019

Feb 14, 2020

SELL
$10.28 - $14.38 $3.89 Million - $5.45 Million
-378,861 Closed
0 $0
Q3 2019

Nov 14, 2019

SELL
$10.05 - $14.55 $4.22 Million - $6.1 Million
-419,476 Reduced 52.54%
378,861 $3.99 Million
Q2 2019

Aug 14, 2019

BUY
$13.1 - $14.95 $5.22 Million - $5.96 Million
398,337 Added 99.58%
798,337 $11.6 Million
Q1 2019

May 14, 2019

BUY
$13.69 - $20.06 $5.48 Million - $8.02 Million
400,000 New
400,000 $5.61 Million

Others Institutions Holding INVA

About Innoviva, Inc.


  • Ticker INVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 69,706,000
  • Market Cap $1.3B
  • Description
  • Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...
More about INVA
Track This Portfolio

Track Antara Capital LP Portfolio

Follow Antara Capital LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Antara Capital LP, based on Form 13F filings with the SEC.

News

Stay updated on Antara Capital LP with notifications on news.